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Abstract
Background: Behcet’s disease is a chronic, multi-systemic autoimmune disease. Programmed cell death 1 (PD-1) gene is one
of non-human leucocyte antigen genes. It has been demonstrated to be associated with several autoimmune diseases.
However, only a few studies have addressed the association of ligand genes of PD-1, PD-L1 and PD-L2 with autoimmune
disease. The purpose of this study was to analyze the potential association of the PD-1 and its ligand genes with Behcet’s
disease in a Chinese Han population.
Methodology/Principal Findings: Four single-nucleotide polymorphism (SNPs) rs2227981 and rs10204525 of PD-1,
rs1970000 of PD-L1 and rs7854303 of PD-L2 were genotyped in 405 Behcet’s patients and 414 age-, sex-, ethnic-matched
healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay. The results revealed that
there were no significant differences in the genotype and allele frequencies of PD-1 rs2227981 and rs10204525 between the
Behcet’s patients and controls. A similar result was found for PD-L1 rs1970000 versus healthy controls. Only the C allele and
the CC genotype of PD-L2 rs7854303 were identified in patients and controls. Stratification analysis based on gender and
clinical findings did not show any associations between PD-1 or its ligand polymorphisms and Behcet’s disease.
Conclusions/Significance: None of the currently studied SNPs, PD-1 rs2227981 and rs10204525, PD-L1 rs1970000 and PD-L2
rs7854303, are associated with the susceptibility to Behcet’s disease in a Chinese Han population. More studies are needed
to confirm these findings in Behcet’s patients with other ethnic backgrounds.
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Introduction
Behcet’s disease is a chronic autoimmune disease characterized
by uveitis, recurrent oral aphthae, genital ulcerations and multiform
skin lesions [1]. It is quite common in countries along the ancient
‘Silk Road’ that extends from the Far East to the Mediterranean
Sea, such as China, Japan and Turkey [1–3]. Although the precise
pathogenesis of Behcet’s disease remains unclear, extensive studies
suggest that an autoimmune response and genetic factors are both
involved in this disease. The human leucocyte antigen B51 (HLA-B51)
gene is demonstrated to be the strongest indicator for this disease in
a variety of ethnic groups [4–7], but it only partly accounts for the
genetic predisposition to Behcet’s disease. Therefore, the role of
non-human leucocyte antigen genes, especially those regulating the
immune response, has recently been investigated by various
laboratories. Immune response genes such as the tumor necrosis factor
alpha (TNF-a) gene [8], SUMO4 gene [9] and IL-23R gene [10],
have been reported to be associated with Behcet’s disease.
Programmed cell death 1 (PD-1) gene is one of non-human
leucocyte antigen genes, located in chromosome 2q37.3 and plays
an important role in the regulation of the immune response [11].
The ligands for PD-1 gene were identified as programmed cell death-1
ligand 1 (PD-L1) and programmed cell death-1 ligand 2 (PD-L2), both of
which are located in 9p24 [11]. PD-1 and its ligands belong to the
CD28:B7 family. PD-1 contains an immunoreceptor tyrosine-
based inhibiting motif (ITIM) and an immunoreceptor tyrosine-
based switch motif (ITSM) [11], which is expressed on activated T
cells, B cells, and myeloid cells [11]. PD-L1 is expressed in T cells,
B cells, macrophages, dendritic cells (DCs), and non-lymphoid
cells, whereas PD-L2 is observed on activated macrophages, DCs
and bone marrow-derived mast cells [11]. Interaction of PD-1
with its ligands could inhibit T-cell receptor-mediated proliferation
and cytokine production [11,12]. PD-1 deficiency results in the
development of a lupus-like disease or a dilated cardiomyopathy in
animal models [13,14]. In mice undergoing anterior chamber–
associated immune deviation, we found that both mRNA and
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and CD4
+PD-1
+ T cells exhibited antigen-specific suppressive
activity [15]. All these results suggest that PD-1 and its ligands are
involved in the regulation of the immune response.
Studies on the PD-1 gene have demonstrated that the
polymorphisms of this gene are associated with several autoim-
mune diseases including systemic lupus erythematosus (SLE) [16–
20], rheumatoid arthritis (RA) [21], type I diabetes [22,23],
multiple sclerosis [24], ankylosing spondylitis (AS) [25], and
Graves’ disease (GD) [26], although there are also some conflicting
results [27–32]. However, only few studies have addressed the
association of ligand genes of PD-1, PD-L1 and PD-L2, with
autoimmune disease [23,33,34].
In this study, we extended earlier studies on the association of
PD-1, PD-L1 or PD-L2 gene polymorphisms with autoimmune
disease, and investigated whether the single-nucleotide polymor-
phisms (SNPs) rs2227981 and rs10204525 of PD-1, rs1970000 of
PD-L1 and rs7854303 of PD-L2 could contribute to the
development of Behcet’s disease in a Chinese Han population.
Results
The clinical characteristics of the enrolled Behcet’s patients
were summarized in Table 1. The average age of the Behcet’s
patients was 32.968.9 and that of healthy controls was 31.4612.5.
All Behcet’s patients with uveitis had recurrent oral aphthae. The
second most common extraocular clinical manifestation was skin
lesions, followed by genital ulcerations. Other abnormalities
included a positive pathergy test and arthritis. The distribution
of genotype frequencies of each SNP in all subjects did not show
any significant deviation from the Hardy–Weinberg equilibrium
(HWE).
Genotype and allele frequencies of the analyzed PD-1
rs2227981 and rs10204525, and PD-L1 rs1970000 were depicted
in Table 2. Our results showed that there were no significantly
differences in the genotype and allele frequencies of rs2227981
and rs10204525 of PD-1 between the Behcet’s patients and
controls. A similar result was found for rs1970000 of PD-L1 versus
healthy controls. The frequency of the GG genotype of rs1970000
tended to be lower in Behcet’s patients than in healthy controls (0
versus 1.4%, P=0.031). However, no difference was found when
the Bonferroni correction was applied (Pc=0.279, n=9).
The PD-L2 rs7854303 T allele could not be found and only the
C allele and the CC genotype were identified in our patients and
controls of the Chinese Han population.
As male gender was predominant in Behcet’s patients, a
stratification analysis according to gender was also performed. The
result showed that there was no association of gender with the four
SNPs. When the genotype and allele frequencies were analyzed
according to the clinical features, our results showed that any of
four SNPs was not found to be associated with any of the
extraocular findings including oral aphthae, genital ulcerations,
skin lesions, positive pathergy test, or arthritis.
Discussion
This study did not detect an association between Behcet’s
disease and known polymorphisms of PD-1 and its ligand genes in
a Chinese Han population. The selection of SNPs used in our
study was principally based on polymorphisms used in earlier
studies. PD-1 rs2227981 polymorphism occurs in an exon which
affects protein synthesis [25]. rs2227981 and rs10204525 of PD-1
have been found to be associated with SLE, AS or RA [19,25,27].
Our previous study has demonstrated that PD-1 rs2227981 may
be negatively associated with the extraocular manifestations of
Vogt-Koyanagi-Harada syndrome in a Chinese Han population
[32]. Although the PD-L1 rs1970000 polymorphism locates in
intron 4, which does not affect an amino acid substitution, it may
be close to or within transcriptional factor-binding sites [23] and
may thus influence the expression of the PD-L1 gene through
modifying the binding affinity of transcriptional factors [34]. This
polymorphism has been shown to be associated with GD in
Japanese patients [34]. PD-L2 rs7854303 C encodes a serine in the
transmembrane region, while PD-L2 rs7854303 T encodes a
phenylalanine. The transmembrane domain may regulate the
expression of the protein molecule on the cell surface [35] and
plays a role in dimerization or oligomerization of cell surface
molecules [36]. The genotype frequency of PD-L2 rs7854303 T/T
has been reported to be significantly increased in patients with
SLE [33].
In order to ensure the analysis results, the following attempts
were made. First, all genotype distributions of four SNPs in
healthy controls were tested and found to be in Hardy–Weinberg
equilibrium. Second, the controls and patients were strictly
matched according to the gender and the places where they were
born to exclude the possible influence of stratification of the
population. Behcet’s patients of Chinese Han descendents were
also strictly selected in this study to avoid the influence of genetic
background. Third, a total of 405 Behcet’s patients and 414 age-,
sex-, ethnically-matched healthy controls were used in this study,
and the number of tested samples was large enough to avoid a bias
of the results. Finally, 20% of the samples were randomly chosen
and analyzed by direct sequencing to validate the genotype
findings. In this study, however, we did not find any association of
PD-1 rs2227981 and rs10204525, PD-L1 rs197000 and PD-L2
rs7854303 SNPs with Behcet’s disease. These results are in
disagreement to those seen in other autoimmune diseases reported
among different ethnic groups [16–27,33,34]. This may be
explained by the fact that the etiology and pathogenesis of
Behcet’s disease may be different from other autoimmune diseases
[3]. In view of the fact that PD-1 and its ligands are mainly
involved in the adaptive immune response, the lack of an
association of PD-1 and its ligands with Behcet’s disease presented
in this study may provide additional evidence to the current
opinion that this disease is an autoinflammatory disease rather
than an autoimmune disease [37,38].
Table 1. Clinical features of the investigated patients with
Behcet’s disease.
Patients with Behcet’s disease
Clinical features Total (n=405) %
Age at onset (years 6 SD) 32.968.9 —
Male 337 83.2
Female 68 16.8
Uveitis 405 100
Oral aphthae 405 100
Skin lesions 255 63.0
Genital ulcerations 198 48.9
Positive pathergy test 132 32.6
Arthritis 107 26.4
Hypopyon 88 21.7
Abbreviations: SD, standardized deviation.
doi:10.1371/journal.pone.0025345.t001
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variation in the frequencies of PD-1 polymorphisms among
different ethnic groups. In the present study, we found a higher
frequency of the PD-1 rs10204525 A allele in Chinese (65%) than
in Caucasican (8.8%–11.5%) [16,17,22] and Mexican (46%) [16].
However, the frequency of the PD-1 rs2227981 C allele in Chinese
was comparable with the frequency in Caucasican [16,17,22],
Mexican [16] and Korean [25] (Table 3). With regards to the
association of PD-L2 rs7854303 polymorphism with autoimmune
disease, a study by Wang et al. [33] showed that an rs7854303
polymorphism was positively associated with SLE in Taiwanese
patients. Their study revealed that the frequencies of the T/T
genotype and T allele were significantly higher in the patients with
SLE than that of the controls. The frequencies of the C/C, C/T
and T/T genotype were 48.1%, 35.0% and 16.9% respectively,
and the C and T allele frequencies were 65.6% and 34.4% in their
160 controls. However, conflicting results were observed among
the Chinese Han population. Only the CC genotype and C allele
of PD-L2 rs7854303 were identified in all Behcet’s patients and
controls in our study, which showed that the polymorphism of PD-
L2 rs7854303 was not associated with Behcet’s disease in Chinese
Han population.
In summary, to the best of our knowledge, this is the first
polymorphism analysis of PD-1 and its ligand genes with Behcet’s
disease in a Chinese Han population. This study did not detect an
association between Behcet’s disease and known polymorphisms of
PD-1 and its ligand genes in a Chinese Han population. A similar
result was observed after stratification analysis based on gender
and extraocular features. More studies are needed to confirm these
findings in Behcet’s patients with other ethnic backgrounds and
whether other SNPs of PD-1 and its ligand genes are possibly
associated with the susceptibility to Behcet’s disease.
Materials and Methods
Clinical Samples
Four hundred and five Behcet’s disease patients who all belong
to the Chinese Han population were recruited in this study. Four
hundred and fourteen age-, sex-, ethnically-matched healthy
controls were mainly the accompanying persons or spouses of the
patients. All patients were recruited from the First Affiliated
Hospital of Chongqing Medical University (Chongqing, China) or
the Uveitis Study Center of the Sun Yat-sen University
(Guangzhou, China). The diagnosis of Behcet’s disease was based
on the criteria of the International Study Group [40].
Ethics statement
The protocol was approved by the Ethics Committee of the First
Affiliated Hospital of Chongqing Medical University, Chongqing,
China (Permit Number: 2009-201004), and written informed
consent was obtained from all the study subjects.
Table 2. Genotype and allele frequencies of PD-1, PD-L1 SNPs in Behcet’s patients and healthy controls.
Gene/SNPs Genotype/allele
Behcet’s patients
(%) (n=405)
Healthy controls
(%) (n=414) X
2 P Odds Ratio (95%CI)
PD-1
rs2227981 CC 234(57.8) 228(55.1) 0.609 0.439 1.116(0.847–1.472)
CT 151(37.3) 161(38.9) 0.224 0.666 0.934(0.705–1.239)
TT 20(4.9) 25(6.0) 0.477 0.541 0.808(0.442–1.480)
C 385(69.2) 389(67.7) 0.332 0.566 1.077(0.838–1.384)
T 171(30.8) 186(32.3) 0.332 0.566 0.929(0.723–1.194)
rs10204525 AA 214(52.8) 211(51.0) 0.288 0.625 1.078(0.819–1.418)
AG 163(40.2) 166(40.1) 0.002 1.000 1.006(0.761–1.331)
GG 28(6.9) 37(8.9) 1.147 0.303 0.757(0.454–1.262)
A 377(66.4) 377(65.0) 0.240 0.663 1.063(0.833–1.356)
G 191(33.6) 203(35.0) 0.240 0.663 0.941(0.737–1.201)
PD-L1
rs1970000 TT 326(80.5) 340(82.1) 0.359 0.591 0.898(0.632–1.277)
GT 79(19.5) 68(16.4) 1.320 0.275 1.233(0.863–1.763)
GG 0(0) 6(1.4) 5.913 0.031* —
T 405(83.7) 408(84.6) 0.170 0.725 0.930(0.658–1.314)
G 79(16.3) 74(15.4) 0.170 0.725 1.075(0.761–1.519)
*, Pc=0.279 (n=9).
doi:10.1371/journal.pone.0025345.t002
Table 3. Differences in allele frequencies of PD-1 rs2227981
and rs10204525 among different ethnic groups.
Population controls PD-1 rs2227981 C PD-1 rs10204525 A
Chinese Han 67.7% 65%
Hong kong Chinese [21] 71% N/A
Taiwanese [39] 70.5% 68.5%
Korean [25] 60.8% N/A
Swedish [16] 57% 9%
Spanish [17] 55.3% 11.5%
Danish [22] 60.5% 8.8%
Mexican [16] 61% 46%
N/A, not available.
doi:10.1371/journal.pone.0025345.t003
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Genomic DNA was isolated from peripheral blood of patients
and controls using the commercial Qiamp DNA Blood Mini Kit
(Qiagen, Valencia, CA). Amplification of the target DNA was
performed by polymerase chain reaction (PCR). The primers used
in this study are presented in Table 4. A 15 ml reaction mixture,
which consisted of 7.5 ml GoTaq Green Mater Mix (Promega,
Madison, WI), 50 pmoles primers, and 0.2 mg of genomic DNA,
was amplified by PCR. PCR conditions were as follows: initial
denaturation at 95uC for 3 min followed by 35 cycles of
denaturation at 94uC for 30 s, annealing at different temperatures
(63uC for rs2227981, rs10204525 and rs1970000, and 58uC for
rs7854303) for 30 s, extension at 72uC for 30 s, and a final
extension at 72uC for 3 min. The SNPs were genotyped by PCR-
restriction fragment length polymorphism (RFLP) analysis. The
PCR products of four SNPs were respectively digested with 2 U of
Pvu II (Promega, Madison, WI), Hsp92 II (Promega, Madison,
WI), Ban II (Promega, Madison, WI) and Mnl I (Fermentas, MBI)
restriction enzymes (Table 4) in a 10 ml reaction volume overnight.
Digestion products were visualized on 3% agarose gels and stained
with GoldView
TM (SBS Genetech, Beijing, China). To confirm the
accuracy of the method employed, randomly selected subjects
(20% of all samples) were analyzed by direct sequencing
(Invitrogen Biotechnology Co., Guangzhou, China). Appropriate
controls (no template and known genotype) were included in each
typing run.
Statistical methods
HWE was tested using the x2 test. Allele frequencies were
estimated by direct counting. Allele and genotype frequencies were
compared between patients and controls by the x2 test using SPSS
(version 16.0; SPSS Inc., Chicago, IL). The P values were
corrected (Pc) with the Bonferroni correction by multiplying with
the number of analyses performed. Pc,0.05 was considered
significant.
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